10 20 30 40 50 60 70 80 2OAT - Header ----|----|----|----|----|----|----|----|----|----|----|----|----|----|----|----| Asymmetric UnitHEADER AMINOTRANSFERASE 07-MAY-98 2OAT
TITLE ORNITHINE AMINOTRANSFERASE COMPLEXED WITH 5-FLUOROMETHYLORNITHINE
COMPND MOL_ID: 1; COMPND 2 MOLECULE: ORNITHINE AMINOTRANSFERASE; COMPND 3 CHAIN: A, B, C; COMPND 4 EC: 2.6.1.13; COMPND 5 ENGINEERED: YES
SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 ORGAN: LIVER; SOURCE 6 ORGANELLE: MITOCHONDRIA; SOURCE 7 CELLULAR_LOCATION: INTRAMITOCHONDRIA; SOURCE 8 GENE: OAT; SOURCE 9 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 10 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 11 EXPRESSION_SYSTEM_STRAIN: TB1; SOURCE 12 EXPRESSION_SYSTEM_PLASMID: PMAL-C2
KEYWDS AMINOTRANSFERASE, 5-FLUOROMETHYLORNITHINE, PLP-DEPENDENT ENZYME, KEYWDS 2 PYRIDOXAL PHOSPHATE
EXPDTA X-RAY DIFFRACTION
AUTHOR P.STORICI,T.SCHIRMER
REVDAT 4 13-JUL-11 2OAT 1 VERSN REVDAT 3 24-FEB-09 2OAT 1 VERSN REVDAT 2 13-JAN-99 2OAT 2 COMPND REMARK LINK JRNL REVDAT 2 2 2 CONECT HETNAM REVDAT 1 09-DEC-98 2OAT 0
JRNL AUTH P.STORICI,G.CAPITANI,R.MULLER,T.SCHIRMER,J.N.JANSONIUS JRNL TITL CRYSTAL STRUCTURE OF HUMAN ORNITHINE AMINOTRANSFERASE JRNL TITL 2 COMPLEXED WITH THE HIGHLY SPECIFIC AND POTENT INHIBITOR JRNL TITL 3 5-FLUOROMETHYLORNITHINE. JRNL REF J.MOL.BIOL. V. 285 297 1999 JRNL REFN ISSN 0022-2836 JRNL PMID 9878407 JRNL DOI 10.1006/JMBI.1998.2289
REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH B.W.SHEN,M.HENNIG,E.HOHENESTER,J.N.JANSONIUS,T.SCHIRMER REMARK 1 TITL CRYSTAL STRUCTURE OF HUMAN RECOMBINANT ORNITHINE REMARK 1 TITL 2 AMINOTRANSFERASE REMARK 1 REF J.MOL.BIOL. V. 277 81 1998 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 2 REMARK 1 AUTH B.W.SHEN,V.RAMESH,R.MUELLER,E.HOHENESTER,M.HENNIG, REMARK 1 AUTH 2 J.N.JANSONIUS REMARK 1 TITL CRYSTALLIZATION AND PRELIMINARY X-RAY DIFFRACTION STUDIES OF REMARK 1 TITL 2 RECOMBINANT HUMAN ORNITHINE AMINOTRANSFERASE REMARK 1 REF J.MOL.BIOL. V. 243 128 1994 REMARK 1 REFN ISSN 0022-2836 REMARK 1 REFERENCE 3 REMARK 1 AUTH F.N.BOLKENIUS,B.KNODGEN,N.SEILER REMARK 1 TITL DL-CANALINE AND 5-FLUOROMETHYLORNITHINE. COMPARISON OF TWO REMARK 1 TITL 2 INACTIVATORS OF ORNITHINE AMINOTRANSFERASE REMARK 1 REF BIOCHEM.J. V. 268 409 1990 REMARK 1 REFN ISSN 0264-6021
REMARK 2 REMARK 2 RESOLUTION. 1.95 ANGSTROMS.
REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC, X-PLOR REMARK 3 AUTHORS : MURSHUDOV,VAGIN,DODSON,BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.95 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 19.60 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 3 NUMBER OF REFLECTIONS : 101836 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.206 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.232 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.000 REMARK 3 FREE R VALUE TEST SET COUNT : 7077 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 9483 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 75 REMARK 3 SOLVENT ATOMS : 744 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.20 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): NULL REMARK 3 ESU BASED ON FREE R VALUE (A): NULL REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): NULL REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 DISTANCE RESTRAINTS. RMS SIGMA REMARK 3 BOND LENGTH (A) : 0.013 ; NULL REMARK 3 ANGLE DISTANCE (A) : 0.021 ; NULL REMARK 3 INTRAPLANAR 1-4 DISTANCE (A) : 0.060 ; NULL REMARK 3 H-BOND OR METAL COORDINATION (A) : NULL ; NULL REMARK 3 REMARK 3 PLANE RESTRAINT (A) : NULL ; NULL REMARK 3 CHIRAL-CENTER RESTRAINT (A**3) : NULL ; NULL REMARK 3 REMARK 3 NON-BONDED CONTACT RESTRAINTS. REMARK 3 SINGLE TORSION (A) : NULL ; NULL REMARK 3 MULTIPLE TORSION (A) : NULL ; NULL REMARK 3 H-BOND (X...Y) (A) : NULL ; NULL REMARK 3 H-BOND (X-H...Y) (A) : NULL ; NULL REMARK 3 REMARK 3 CONFORMATIONAL TORSION ANGLE RESTRAINTS. REMARK 3 SPECIFIED (DEGREES) : NULL ; NULL REMARK 3 PLANAR (DEGREES) : NULL ; NULL REMARK 3 STAGGERED (DEGREES) : NULL ; NULL REMARK 3 TRANSVERSE (DEGREES) : NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4 REMARK 4 2OAT COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL.
REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : NOV-96 REMARK 200 TEMPERATURE (KELVIN) : 90 REMARK 200 PH : 7.9 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : MPG/DESY, HAMBURG REMARK 200 BEAMLINE : BW6 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1 REMARK 200 MONOCHROMATOR : GRAPHITE(002) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 101836 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.950 REMARK 200 RESOLUTION RANGE LOW (A) : 19.900 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 97.0 REMARK 200 DATA REDUNDANCY : 3.200 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.07600 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 12.5000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.95 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.98 REMARK 200 COMPLETENESS FOR SHELL (%) : 94.0 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.35000 REMARK 200 <I/SIGMA(I)> FOR SHELL : 3.400 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: DIFFERENCE FOURIER REMARK 200 TECHNIQUES REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: 1OAT REMARK 200 REMARK 200 REMARK: NULL
REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.90 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.65 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: (2S,5S)5FMORN-OAT WAS CO-CRYSTALLIZED REMARK 280 FROM 6-10% PEG 6000, 1MM DTT, 120-160 MM NACL, 10-20% GLYCEROL, REMARK 280 50 MM TRICIN, PH 7.9.
REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 4555 Y,X,-Z REMARK 290 5555 X-Y,-Y,-Z+1/3 REMARK 290 6555 -X,-X+Y,-Z+2/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 124.54000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 62.27000 REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 62.27000 REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 124.54000 REMARK 290 REMARK 290 REMARK: NULL
REMARK 300 REMARK 300 BIOMOLECULE: 1, 2, 3 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THERE ARE ONE AND A HALF DIMERS IN THE ASYMMETRIC UNIT. REMARK 300 CHAINS A AND B REFER TO THE TWO SUBUNITS OF THE FIRST REMARK 300 DIMER. CHAIN C REFERS TO ONE SUBUNIT OF THE SECOND DIMER; REMARK 300 THE OTHER SUBUNIT IS RELATED BY CRYSTAL SYMMETRY.
REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 1 0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 -1.000000 0.00000 REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 2 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 2 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 12100 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25560 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -62.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 3 REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA,PQS REMARK 350 TOTAL BURIED SURFACE AREA: 12120 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 25520 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -62.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 BIOMT1 2 -0.500000 0.866025 0.000000 0.00000 REMARK 350 BIOMT2 2 0.866025 0.500000 0.000000 0.00000 REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 0.00000
REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 PHE A 2 REMARK 465 SER A 3 REMARK 465 LYS A 4 REMARK 465 LEU A 5 REMARK 465 ALA A 6 REMARK 465 HIS A 7 REMARK 465 LEU A 8 REMARK 465 GLN A 9 REMARK 465 ARG A 10 REMARK 465 PHE A 11 REMARK 465 ALA A 12 REMARK 465 VAL A 13 REMARK 465 LEU A 14 REMARK 465 SER A 15 REMARK 465 ARG A 16 REMARK 465 GLY A 17 REMARK 465 VAL A 18 REMARK 465 HIS A 19 REMARK 465 SER A 20 REMARK 465 SER A 21 REMARK 465 VAL A 22 REMARK 465 ALA A 23 REMARK 465 SER A 24 REMARK 465 ALA A 25 REMARK 465 THR A 26 REMARK 465 SER A 27 REMARK 465 VAL A 28 REMARK 465 ALA A 29 REMARK 465 THR A 30 REMARK 465 LYS A 31 REMARK 465 LYS A 32 REMARK 465 THR A 33 REMARK 465 VAL A 34 REMARK 465 GLN A 35 REMARK 465 MET B 1 REMARK 465 PHE B 2 REMARK 465 SER B 3 REMARK 465 LYS B 4 REMARK 465 LEU B 5 REMARK 465 ALA B 6 REMARK 465 HIS B 7 REMARK 465 LEU B 8 REMARK 465 GLN B 9 REMARK 465 ARG B 10 REMARK 465 PHE B 11 REMARK 465 ALA B 12 REMARK 465 VAL B 13 REMARK 465 LEU B 14 REMARK 465 SER B 15 REMARK 465 ARG B 16 REMARK 465 GLY B 17 REMARK 465 VAL B 18 REMARK 465 HIS B 19 REMARK 465 SER B 20 REMARK 465 SER B 21 REMARK 465 VAL B 22 REMARK 465 ALA B 23 REMARK 465 SER B 24 REMARK 465 ALA B 25 REMARK 465 THR B 26 REMARK 465 SER B 27 REMARK 465 VAL B 28 REMARK 465 ALA B 29 REMARK 465 THR B 30 REMARK 465 LYS B 31 REMARK 465 LYS B 32 REMARK 465 THR B 33 REMARK 465 VAL B 34 REMARK 465 GLN B 35 REMARK 465 MET C 1 REMARK 465 PHE C 2 REMARK 465 SER C 3 REMARK 465 LYS C 4 REMARK 465 LEU C 5 REMARK 465 ALA C 6 REMARK 465 HIS C 7 REMARK 465 LEU C 8 REMARK 465 GLN C 9 REMARK 465 ARG C 10 REMARK 465 PHE C 11 REMARK 465 ALA C 12 REMARK 465 VAL C 13 REMARK 465 LEU C 14 REMARK 465 SER C 15 REMARK 465 ARG C 16 REMARK 465 GLY C 17 REMARK 465 VAL C 18 REMARK 465 HIS C 19 REMARK 465 SER C 20 REMARK 465 SER C 21 REMARK 465 VAL C 22 REMARK 465 ALA C 23 REMARK 465 SER C 24 REMARK 465 ALA C 25 REMARK 465 THR C 26 REMARK 465 SER C 27 REMARK 465 VAL C 28 REMARK 465 ALA C 29 REMARK 465 THR C 30 REMARK 465 LYS C 31 REMARK 465 LYS C 32 REMARK 465 THR C 33 REMARK 465 VAL C 34 REMARK 465 GLN C 35
REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OA PFM C 440 O HOH C 556 2.07 REMARK 500 O HOH B 474 O HOH B 645 2.09 REMARK 500 O HOH B 455 O HOH B 464 2.13 REMARK 500 NZ LYS C 405 O HOH C 694 2.16 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU B 252 CA - CB - CG ANGL. DEV. = 15.0 DEGREES REMARK 500 ASP B 387 CB - CG - OD1 ANGL. DEV. = 5.5 DEGREES REMARK 500 ARG B 413 NE - CZ - NH1 ANGL. DEV. = 3.1 DEGREES REMARK 500 ARG C 113 NE - CZ - NH1 ANGL. DEV. = -3.5 DEGREES REMARK 500 ARG C 357 CD - NE - CZ ANGL. DEV. = 8.5 DEGREES REMARK 500 ARG C 413 CD - NE - CZ ANGL. DEV. = 16.7 DEGREES REMARK 500 ARG C 413 NE - CZ - NH1 ANGL. DEV. = 3.3 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 HIS A 53 46.27 -99.34 REMARK 500 PRO A 59 87.12 -65.46 REMARK 500 SER A 86 -9.91 91.21 REMARK 500 VAL A 88 50.99 -104.43 REMARK 500 SER A 112 170.05 80.18 REMARK 500 TYR A 166 70.08 -119.37 REMARK 500 ALA A 270 -11.58 74.32 REMARK 500 LYS A 292 -98.61 38.47 REMARK 500 TYR A 299 142.29 -172.94 REMARK 500 SER A 321 141.86 -174.82 REMARK 500 HIS A 408 -165.79 165.99 REMARK 500 PRO A 417 152.13 -49.86 REMARK 500 HIS B 53 41.19 -96.91 REMARK 500 PRO B 59 91.07 -69.74 REMARK 500 VAL B 88 51.65 -107.39 REMARK 500 LEU B 108 129.35 -171.87 REMARK 500 SER B 112 166.28 78.79 REMARK 500 ALA B 270 -7.86 71.22 REMARK 500 LYS B 292 -99.79 41.65 REMARK 500 HIS B 408 -169.77 -173.18 REMARK 500 HIS C 53 43.00 -98.29 REMARK 500 SER C 86 -9.72 95.56 REMARK 500 VAL C 88 53.20 -105.81 REMARK 500 LYS C 107 -61.38 -95.57 REMARK 500 SER C 112 168.64 83.44 REMARK 500 TYR C 166 68.16 -119.13 REMARK 500 TRP C 178 18.42 -140.41 REMARK 500 ALA C 270 -12.24 69.85 REMARK 500 LYS C 292 -93.79 43.44 REMARK 500 TYR C 299 139.61 -170.73 REMARK 500 HIS C 319 148.50 -172.69 REMARK 500 SER C 321 137.69 -175.92 REMARK 500 HIS C 408 -153.43 138.63 REMARK 500 REMARK 500 REMARK: NULL
REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH A 527 DISTANCE = 6.57 ANGSTROMS REMARK 525 HOH A 621 DISTANCE = 5.47 ANGSTROMS REMARK 525 HOH A 624 DISTANCE = 7.16 ANGSTROMS REMARK 525 HOH A 655 DISTANCE = 5.63 ANGSTROMS REMARK 525 HOH C 641 DISTANCE = 5.86 ANGSTROMS
REMARK 615 REMARK 615 ZERO OCCUPANCY ATOM REMARK 615 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 615 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 615 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 615 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 615 M RES C SSEQI REMARK 615 HOH A 555 REMARK 615 HOH A 653 REMARK 615 HOH C 571
REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: FMA REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: THE INHIBITOR-COFACTOR ADDUCT HAS AN ABSORPTION REMARK 800 MAXIMUM AT 458NM AND IS NON-COVALENTLY BOUND TO THE ACTIVE SITE REMARK 800 RESIDUES. REMARK 800 REMARK 800 SITE_IDENTIFIER: FMB REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: THE INHIBITOR-COFACTOR ADDUCT HAS AN ABSORPTION REMARK 800 MAXIMUM AT 458NM AND IS NON-COVALENTLY BOUND TO THE ACTIVE SITE REMARK 800 RESIDUES. REMARK 800 REMARK 800 SITE_IDENTIFIER: FMC REMARK 800 EVIDENCE_CODE: UNKNOWN REMARK 800 SITE_DESCRIPTION: THE INHIBITOR-COFACTOR ADDUCT HAS AN ABSORPTION REMARK 800 MAXIMUM AT 458NM AND IS NON-COVALENTLY BOUND TO THE ACTIVE SITE REMARK 800 RESIDUES. REMARK 800 REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PFM A 440 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PFM B 440 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE PFM C 440
DBREF 2OAT A 1 439 UNP P04181 OAT_HUMAN 1 439 DBREF 2OAT B 1 439 UNP P04181 OAT_HUMAN 1 439 DBREF 2OAT C 1 439 UNP P04181 OAT_HUMAN 1 439
SEQRES 1 A 439 MET PHE SER LYS LEU ALA HIS LEU GLN ARG PHE ALA VAL SEQRES 2 A 439 LEU SER ARG GLY VAL HIS SER SER VAL ALA SER ALA THR SEQRES 3 A 439 SER VAL ALA THR LYS LYS THR VAL GLN GLY PRO PRO THR SEQRES 4 A 439 SER ASP ASP ILE PHE GLU ARG GLU TYR LYS TYR GLY ALA SEQRES 5 A 439 HIS ASN TYR HIS PRO LEU PRO VAL ALA LEU GLU ARG GLY SEQRES 6 A 439 LYS GLY ILE TYR LEU TRP ASP VAL GLU GLY ARG LYS TYR SEQRES 7 A 439 PHE ASP PHE LEU SER SER TYR SER ALA VAL ASN GLN GLY SEQRES 8 A 439 HIS CYS HIS PRO LYS ILE VAL ASN ALA LEU LYS SER GLN SEQRES 9 A 439 VAL ASP LYS LEU THR LEU THR SER ARG ALA PHE TYR ASN SEQRES 10 A 439 ASN VAL LEU GLY GLU TYR GLU GLU TYR ILE THR LYS LEU SEQRES 11 A 439 PHE ASN TYR HIS LYS VAL LEU PRO MET ASN THR GLY VAL SEQRES 12 A 439 GLU ALA GLY GLU THR ALA CYS LYS LEU ALA ARG LYS TRP SEQRES 13 A 439 GLY TYR THR VAL LYS GLY ILE GLN LYS TYR LYS ALA LYS SEQRES 14 A 439 ILE VAL PHE ALA ALA GLY ASN PHE TRP GLY ARG THR LEU SEQRES 15 A 439 SER ALA ILE SER SER SER THR ASP PRO THR SER TYR ASP SEQRES 16 A 439 GLY PHE GLY PRO PHE MET PRO GLY PHE ASP ILE ILE PRO SEQRES 17 A 439 TYR ASN ASP LEU PRO ALA LEU GLU ARG ALA LEU GLN ASP SEQRES 18 A 439 PRO ASN VAL ALA ALA PHE MET VAL GLU PRO ILE GLN GLY SEQRES 19 A 439 GLU ALA GLY VAL VAL VAL PRO ASP PRO GLY TYR LEU MET SEQRES 20 A 439 GLY VAL ARG GLU LEU CYS THR ARG HIS GLN VAL LEU PHE SEQRES 21 A 439 ILE ALA ASP GLU ILE GLN THR GLY LEU ALA ARG THR GLY SEQRES 22 A 439 ARG TRP LEU ALA VAL ASP TYR GLU ASN VAL ARG PRO ASP SEQRES 23 A 439 ILE VAL LEU LEU GLY LYS ALA LEU SER GLY GLY LEU TYR SEQRES 24 A 439 PRO VAL SER ALA VAL LEU CYS ASP ASP ASP ILE MET LEU SEQRES 25 A 439 THR ILE LYS PRO GLY GLU HIS GLY SER THR TYR GLY GLY SEQRES 26 A 439 ASN PRO LEU GLY CYS ARG VAL ALA ILE ALA ALA LEU GLU SEQRES 27 A 439 VAL LEU GLU GLU GLU ASN LEU ALA GLU ASN ALA ASP LYS SEQRES 28 A 439 LEU GLY ILE ILE LEU ARG ASN GLU LEU MET LYS LEU PRO SEQRES 29 A 439 SER ASP VAL VAL THR ALA VAL ARG GLY LYS GLY LEU LEU SEQRES 30 A 439 ASN ALA ILE VAL ILE LYS GLU THR LYS ASP TRP ASP ALA SEQRES 31 A 439 TRP LYS VAL CYS LEU ARG LEU ARG ASP ASN GLY LEU LEU SEQRES 32 A 439 ALA LYS PRO THR HIS GLY ASP ILE ILE ARG PHE ALA PRO SEQRES 33 A 439 PRO LEU VAL ILE LYS GLU ASP GLU LEU ARG GLU SER ILE SEQRES 34 A 439 GLU ILE ILE ASN LYS THR ILE LEU SER PHE SEQRES 1 B 439 MET PHE SER LYS LEU ALA HIS LEU GLN ARG PHE ALA VAL SEQRES 2 B 439 LEU SER ARG GLY VAL HIS SER SER VAL ALA SER ALA THR SEQRES 3 B 439 SER VAL ALA THR LYS LYS THR VAL GLN GLY PRO PRO THR SEQRES 4 B 439 SER ASP ASP ILE PHE GLU ARG GLU TYR LYS TYR GLY ALA SEQRES 5 B 439 HIS ASN TYR HIS PRO LEU PRO VAL ALA LEU GLU ARG GLY SEQRES 6 B 439 LYS GLY ILE TYR LEU TRP ASP VAL GLU GLY ARG LYS TYR SEQRES 7 B 439 PHE ASP PHE LEU SER SER TYR SER ALA VAL ASN GLN GLY SEQRES 8 B 439 HIS CYS HIS PRO LYS ILE VAL ASN ALA LEU LYS SER GLN SEQRES 9 B 439 VAL ASP LYS LEU THR LEU THR SER ARG ALA PHE TYR ASN SEQRES 10 B 439 ASN VAL LEU GLY GLU TYR GLU GLU TYR ILE THR LYS LEU SEQRES 11 B 439 PHE ASN TYR HIS LYS VAL LEU PRO MET ASN THR GLY VAL SEQRES 12 B 439 GLU ALA GLY GLU THR ALA CYS LYS LEU ALA ARG LYS TRP SEQRES 13 B 439 GLY TYR THR VAL LYS GLY ILE GLN LYS TYR LYS ALA LYS SEQRES 14 B 439 ILE VAL PHE ALA ALA GLY ASN PHE TRP GLY ARG THR LEU SEQRES 15 B 439 SER ALA ILE SER SER SER THR ASP PRO THR SER TYR ASP SEQRES 16 B 439 GLY PHE GLY PRO PHE MET PRO GLY PHE ASP ILE ILE PRO SEQRES 17 B 439 TYR ASN ASP LEU PRO ALA LEU GLU ARG ALA LEU GLN ASP SEQRES 18 B 439 PRO ASN VAL ALA ALA PHE MET VAL GLU PRO ILE GLN GLY SEQRES 19 B 439 GLU ALA GLY VAL VAL VAL PRO ASP PRO GLY TYR LEU MET SEQRES 20 B 439 GLY VAL ARG GLU LEU CYS THR ARG HIS GLN VAL LEU PHE SEQRES 21 B 439 ILE ALA ASP GLU ILE GLN THR GLY LEU ALA ARG THR GLY SEQRES 22 B 439 ARG TRP LEU ALA VAL ASP TYR GLU ASN VAL ARG PRO ASP SEQRES 23 B 439 ILE VAL LEU LEU GLY LYS ALA LEU SER GLY GLY LEU TYR SEQRES 24 B 439 PRO VAL SER ALA VAL LEU CYS ASP ASP ASP ILE MET LEU SEQRES 25 B 439 THR ILE LYS PRO GLY GLU HIS GLY SER THR TYR GLY GLY SEQRES 26 B 439 ASN PRO LEU GLY CYS ARG VAL ALA ILE ALA ALA LEU GLU SEQRES 27 B 439 VAL LEU GLU GLU GLU ASN LEU ALA GLU ASN ALA ASP LYS SEQRES 28 B 439 LEU GLY ILE ILE LEU ARG ASN GLU LEU MET LYS LEU PRO SEQRES 29 B 439 SER ASP VAL VAL THR ALA VAL ARG GLY LYS GLY LEU LEU SEQRES 30 B 439 ASN ALA ILE VAL ILE LYS GLU THR LYS ASP TRP ASP ALA SEQRES 31 B 439 TRP LYS VAL CYS LEU ARG LEU ARG ASP ASN GLY LEU LEU SEQRES 32 B 439 ALA LYS PRO THR HIS GLY ASP ILE ILE ARG PHE ALA PRO SEQRES 33 B 439 PRO LEU VAL ILE LYS GLU ASP GLU LEU ARG GLU SER ILE SEQRES 34 B 439 GLU ILE ILE ASN LYS THR ILE LEU SER PHE SEQRES 1 C 439 MET PHE SER LYS LEU ALA HIS LEU GLN ARG PHE ALA VAL SEQRES 2 C 439 LEU SER ARG GLY VAL HIS SER SER VAL ALA SER ALA THR SEQRES 3 C 439 SER VAL ALA THR LYS LYS THR VAL GLN GLY PRO PRO THR SEQRES 4 C 439 SER ASP ASP ILE PHE GLU ARG GLU TYR LYS TYR GLY ALA SEQRES 5 C 439 HIS ASN TYR HIS PRO LEU PRO VAL ALA LEU GLU ARG GLY SEQRES 6 C 439 LYS GLY ILE TYR LEU TRP ASP VAL GLU GLY ARG LYS TYR SEQRES 7 C 439 PHE ASP PHE LEU SER SER TYR SER ALA VAL ASN GLN GLY SEQRES 8 C 439 HIS CYS HIS PRO LYS ILE VAL ASN ALA LEU LYS SER GLN SEQRES 9 C 439 VAL ASP LYS LEU THR LEU THR SER ARG ALA PHE TYR ASN SEQRES 10 C 439 ASN VAL LEU GLY GLU TYR GLU GLU TYR ILE THR LYS LEU SEQRES 11 C 439 PHE ASN TYR HIS LYS VAL LEU PRO MET ASN THR GLY VAL SEQRES 12 C 439 GLU ALA GLY GLU THR ALA CYS LYS LEU ALA ARG LYS TRP SEQRES 13 C 439 GLY TYR THR VAL LYS GLY ILE GLN LYS TYR LYS ALA LYS SEQRES 14 C 439 ILE VAL PHE ALA ALA GLY ASN PHE TRP GLY ARG THR LEU SEQRES 15 C 439 SER ALA ILE SER SER SER THR ASP PRO THR SER TYR ASP SEQRES 16 C 439 GLY PHE GLY PRO PHE MET PRO GLY PHE ASP ILE ILE PRO SEQRES 17 C 439 TYR ASN ASP LEU PRO ALA LEU GLU ARG ALA LEU GLN ASP SEQRES 18 C 439 PRO ASN VAL ALA ALA PHE MET VAL GLU PRO ILE GLN GLY SEQRES 19 C 439 GLU ALA GLY VAL VAL VAL PRO ASP PRO GLY TYR LEU MET SEQRES 20 C 439 GLY VAL ARG GLU LEU CYS THR ARG HIS GLN VAL LEU PHE SEQRES 21 C 439 ILE ALA ASP GLU ILE GLN THR GLY LEU ALA ARG THR GLY SEQRES 22 C 439 ARG TRP LEU ALA VAL ASP TYR GLU ASN VAL ARG PRO ASP SEQRES 23 C 439 ILE VAL LEU LEU GLY LYS ALA LEU SER GLY GLY LEU TYR SEQRES 24 C 439 PRO VAL SER ALA VAL LEU CYS ASP ASP ASP ILE MET LEU SEQRES 25 C 439 THR ILE LYS PRO GLY GLU HIS GLY SER THR TYR GLY GLY SEQRES 26 C 439 ASN PRO LEU GLY CYS ARG VAL ALA ILE ALA ALA LEU GLU SEQRES 27 C 439 VAL LEU GLU GLU GLU ASN LEU ALA GLU ASN ALA ASP LYS SEQRES 28 C 439 LEU GLY ILE ILE LEU ARG ASN GLU LEU MET LYS LEU PRO SEQRES 29 C 439 SER ASP VAL VAL THR ALA VAL ARG GLY LYS GLY LEU LEU SEQRES 30 C 439 ASN ALA ILE VAL ILE LYS GLU THR LYS ASP TRP ASP ALA SEQRES 31 C 439 TRP LYS VAL CYS LEU ARG LEU ARG ASP ASN GLY LEU LEU SEQRES 32 C 439 ALA LYS PRO THR HIS GLY ASP ILE ILE ARG PHE ALA PRO SEQRES 33 C 439 PRO LEU VAL ILE LYS GLU ASP GLU LEU ARG GLU SER ILE SEQRES 34 C 439 GLU ILE ILE ASN LYS THR ILE LEU SER PHE
HET PFM A 440 25 HET PFM B 440 25 HET PFM C 440 25
HETNAM PFM 1-AMINO-7-(2-METHYL-3-OXIDO-5-((PHOSPHONOXY)METHYL)-4- HETNAM 2 PFM PYRIDOXAL-5-OXO-6-HEPTENATE
HETSYN PFM PYRIDOXYLIDENE-PROPEN-1-YL-3-ALANINE-5-PHOSPHATE
FORMUL 4 PFM 3(C14 H19 N2 O8 P) FORMUL 7 HOH *744(H2 O)
HELIX 1 1 SER A 40 TYR A 50 1 11 HELIX 2 2 SER A 83 SER A 86 1 4 HELIX 3 3 PRO A 95 VAL A 105 1 11 HELIX 4 4 LEU A 120 PHE A 131 1 12 HELIX 5 5 GLY A 142 THR A 159 1 18 HELIX 6 6 ALA A 184 SER A 187 5 4 HELIX 7 7 PRO A 191 TYR A 194 1 4 HELIX 8 8 LEU A 212 GLN A 220 1 9 HELIX 9 9 TYR A 245 HIS A 256 1 12 HELIX 10 10 ALA A 277 GLU A 281 5 5 HELIX 11 11 ASP A 308 THR A 313 1 6 HELIX 12 12 PRO A 327 GLU A 342 1 16 HELIX 13 13 LEU A 345 LYS A 362 1 18 HELIX 14 14 ALA A 390 ASP A 399 1 10 HELIX 15 15 GLU A 422 SER A 438 1 17 HELIX 16 16 SER B 40 TYR B 50 1 11 HELIX 17 17 SER B 83 SER B 86 1 4 HELIX 18 18 PRO B 95 VAL B 105 1 11 HELIX 19 19 LEU B 120 PHE B 131 1 12 HELIX 20 20 GLY B 142 THR B 159 1 18 HELIX 21 21 LEU B 182 SER B 187 1 6 HELIX 22 22 PRO B 191 TYR B 194 1 4 HELIX 23 23 LEU B 212 GLN B 220 1 9 HELIX 24 24 TYR B 245 HIS B 256 1 12 HELIX 25 25 ALA B 277 GLU B 281 5 5 HELIX 26 26 ASP B 308 THR B 313 1 6 HELIX 27 27 PRO B 327 GLU B 342 1 16 HELIX 28 28 LEU B 345 LYS B 362 1 18 HELIX 29 29 ALA B 390 ASP B 399 1 10 HELIX 30 30 GLU B 422 SER B 438 1 17 HELIX 31 31 SER C 40 TYR C 50 1 11 HELIX 32 32 SER C 83 SER C 86 1 4 HELIX 33 33 PRO C 95 VAL C 105 1 11 HELIX 34 34 LEU C 120 PHE C 131 1 12 HELIX 35 35 GLY C 142 THR C 159 1 18 HELIX 36 36 LEU C 182 SER C 187 1 6 HELIX 37 37 PRO C 191 TYR C 194 1 4 HELIX 38 38 LEU C 212 GLN C 220 1 9 HELIX 39 39 TYR C 245 HIS C 256 1 12 HELIX 40 40 ALA C 277 GLU C 281 5 5 HELIX 41 41 ASP C 308 THR C 313 1 6 HELIX 42 42 PRO C 327 GLU C 342 1 16 HELIX 43 43 LEU C 345 LYS C 362 1 18 HELIX 44 44 ALA C 390 ASP C 399 1 10 HELIX 45 45 GLU C 422 LEU C 437 1 16
SHEET 1 A 3 LYS A 77 PHE A 79 0 SHEET 2 A 3 TYR A 69 ASP A 72 -1 N LEU A 70 O TYR A 78 SHEET 3 A 3 LEU A 62 LYS A 66 -1 N LYS A 66 O TYR A 69 SHEET 1 B 7 LYS A 135 MET A 139 0 SHEET 2 B 7 SER A 302 CYS A 306 -1 N CYS A 306 O LYS A 135 SHEET 3 B 7 ILE A 287 LEU A 290 -1 N LEU A 290 O ALA A 303 SHEET 4 B 7 LEU A 259 ASP A 263 1 N ALA A 262 O ILE A 287 SHEET 5 B 7 VAL A 224 GLU A 230 1 N PHE A 227 O LEU A 259 SHEET 6 B 7 LYS A 169 ALA A 173 1 N LYS A 169 O ALA A 225 SHEET 7 B 7 PHE A 204 ILE A 207 1 N ASP A 205 O ILE A 170 SHEET 1 C 3 ILE A 411 PHE A 414 0 SHEET 2 C 3 LEU A 377 ILE A 382 -1 N ILE A 380 O ILE A 412 SHEET 3 C 3 VAL A 368 LYS A 374 -1 N LYS A 374 O LEU A 377 SHEET 1 D 4 LYS B 77 PHE B 79 0 SHEET 2 D 4 TYR B 69 ASP B 72 -1 N LEU B 70 O TYR B 78 SHEET 3 D 4 LEU B 58 LYS B 66 -1 N LYS B 66 O TYR B 69 SHEET 4 D 4 PHE A 115 ASN A 117 1 N TYR A 116 O LEU B 58 SHEET 1 E 7 LYS B 135 MET B 139 0 SHEET 2 E 7 SER B 302 CYS B 306 -1 N CYS B 306 O LYS B 135 SHEET 3 E 7 ILE B 287 LEU B 290 -1 N LEU B 290 O ALA B 303 SHEET 4 E 7 LEU B 259 ASP B 263 1 N ALA B 262 O ILE B 287 SHEET 5 E 7 VAL B 224 VAL B 229 1 N PHE B 227 O LEU B 259 SHEET 6 E 7 LYS B 169 ALA B 173 1 N LYS B 169 O ALA B 225 SHEET 7 E 7 PHE B 204 ILE B 207 1 N ASP B 205 O ILE B 170 SHEET 1 F 3 ILE B 411 PHE B 414 0 SHEET 2 F 3 LEU B 377 ILE B 382 -1 N ILE B 380 O ILE B 412 SHEET 3 F 3 VAL B 368 LYS B 374 -1 N LYS B 374 O LEU B 377 SHEET 1 G 3 LYS C 77 PHE C 79 0 SHEET 2 G 3 TYR C 69 ASP C 72 -1 N LEU C 70 O TYR C 78 SHEET 3 G 3 LEU C 62 LYS C 66 -1 N LYS C 66 O TYR C 69 SHEET 1 H 7 LYS C 135 MET C 139 0 SHEET 2 H 7 SER C 302 CYS C 306 -1 N CYS C 306 O LYS C 135 SHEET 3 H 7 ILE C 287 LEU C 290 -1 N LEU C 290 O ALA C 303 SHEET 4 H 7 LEU C 259 ASP C 263 1 N ALA C 262 O ILE C 287 SHEET 5 H 7 VAL C 224 GLU C 230 1 N PHE C 227 O LEU C 259 SHEET 6 H 7 LYS C 169 ALA C 173 1 N LYS C 169 O ALA C 225 SHEET 7 H 7 PHE C 204 ILE C 207 1 N ASP C 205 O ILE C 170 SHEET 1 I 3 ILE C 411 PHE C 414 0 SHEET 2 I 3 LEU C 377 ILE C 382 -1 N ILE C 380 O ILE C 412 SHEET 3 I 3 VAL C 368 LYS C 374 -1 N LYS C 374 O LEU C 377
CISPEP 1 LYS A 165 TYR A 166 0 -1.70 CISPEP 2 GLY A 198 PRO A 199 0 7.82 CISPEP 3 LYS B 165 TYR B 166 0 -0.06 CISPEP 4 GLY B 198 PRO B 199 0 8.04 CISPEP 5 LYS C 165 TYR C 166 0 -1.23 CISPEP 6 GLY C 198 PRO C 199 0 7.25
SITE 1 FMA 1 PFM A 440 SITE 1 FMB 1 PFM B 440 SITE 1 FMC 1 PFM C 440 SITE 1 AC1 21 TYR A 55 THR A 141 GLY A 142 VAL A 143 SITE 2 AC1 21 PHE A 177 TRP A 178 ARG A 180 GLU A 230 SITE 3 AC1 21 GLU A 235 ASP A 263 GLN A 266 LYS A 292 SITE 4 AC1 21 HOH A 473 HOH A 514 HOH A 543 HOH A 545 SITE 5 AC1 21 HOH A 643 GLY B 320 SER B 321 THR B 322 SITE 6 AC1 21 HOH B 524 SITE 1 AC2 23 GLY A 320 SER A 321 THR A 322 HOH A 512 SITE 2 AC2 23 HOH A 644 TYR B 55 TYR B 85 THR B 141 SITE 3 AC2 23 GLY B 142 VAL B 143 PHE B 177 TRP B 178 SITE 4 AC2 23 ARG B 180 GLU B 230 ASP B 263 ILE B 265 SITE 5 AC2 23 GLN B 266 LYS B 292 HOH B 444 HOH B 489 SITE 6 AC2 23 HOH B 526 HOH B 555 HOH B 558 SITE 1 AC3 23 TYR C 55 TYR C 85 THR C 141 GLY C 142 SITE 2 AC3 23 VAL C 143 PHE C 177 TRP C 178 ARG C 180 SITE 3 AC3 23 GLU C 230 ASP C 263 ILE C 265 GLN C 266 SITE 4 AC3 23 LYS C 292 GLY C 320 SER C 321 THR C 322 SITE 5 AC3 23 HOH C 478 HOH C 507 HOH C 522 HOH C 524 SITE 6 AC3 23 HOH C 556 HOH C 559 HOH C 673
CRYST1 115.280 115.280 186.810 90.00 90.00 120.00 P 32 2 1 18
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.008675 0.005008 0.000000 0.00000
SCALE2 0.000000 0.010016 0.000000 0.00000
SCALE3 0.000000 0.000000 0.005353 0.00000
MTRIX1 1 0.899700 0.062500 -0.432000 7.62690 1
MTRIX2 1 0.062500 -0.997900 -0.014200 73.10220 1
MTRIX3 1 -0.432000 -0.014200 -0.901800 44.11250 1
MTRIX1 2 -0.444900 0.776800 0.445800 -1.34480 1
MTRIX2 2 -0.868300 -0.496000 -0.002400 81.55940 1
MTRIX3 2 0.219200 -0.388100 0.895100 -6.46180 1